{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:16:10Z","timestamp":1771841770580,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several studies have found an association of COVID-19 disease severity with Vitamin D deficiency and higher levels of anti-SARS-CoV-2 IgGs. The aim of this study was to determine whether levels of Vitamin D and \u201cinflammatory state\u201d influence the magnitude of anti-SARS-CoV-2 IgGs levels in COVID-19 patients. For this purpose, in 67 patients levels of anti-SARS-CoV-2 IgG were measured in week 4 whereas in 52 patients levels of Vitamin D were measured in week 1 after symptom onset. We found that low Vitamin D levels were significantly associated with age and disease severity whereas there was a trend without significance, towards negative correlation of Vitamin D with anti-SARS-CoV-2 IgG. Anti-SARS-CoV-2 IgG were significantly higher in older ages, patients with severe disease, diabetes and those who received corticosteroid and antibiotic therapy. There was a positive correlation of anti-SARS-CoV-2 IgG with IL-6, CRP, LDH, ESR and with percentages of granulocytes. In conclusion, Vitamin D and anti-SARS-CoV-2 IgG share common parameters associated with inflammatory state. However, even though Vitamin D protects against severe forms of COVID-19 it could not directly affect anti-SARS-CoV-2 IgG production.<\/jats:p>","DOI":"10.1038\/s41598-022-09785-7","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T17:03:16Z","timestamp":1649178196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Relationship of anti-SARS-CoV-2 IgG antibodies with Vitamin D and inflammatory markers in COVID-19 patients"],"prefix":"10.1038","volume":"12","author":[{"given":"Hatixhe","family":"Latifi-Pupovci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadie","family":"Namani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artina","family":"Pajaziti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blerina","family":"Ahmetaj-Shala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindita","family":"Ajazaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afrim","family":"Kotori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valdete","family":"Haxhibeqiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Gegaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gramoz","family":"Bunjaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"issue":"4","key":"9785_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/bjh.16938","volume":"190","author":"TM Thomson","year":"2020","unstructured":"Thomson, T. M., Toscano-Guerra, E., Casis, E. & Paciucci, R. C1 esterase inhibitor and the contact system in COVID-19. Br. J. Haematol. 190(4), 520\u2013524. https:\/\/doi.org\/10.1111\/bjh.16938 (2020).","journal-title":"Br. J. Haematol."},{"key":"9785_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.613422","volume":"12","author":"A Santa Cruz","year":"2021","unstructured":"Santa Cruz, A. et al. Interleukin-6 Is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 oxi. Front. Immunol. 12, 613422. https:\/\/doi.org\/10.3389\/fimmu.2021.613422 (2021).","journal-title":"Front. Immunol."},{"key":"9785_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.629193","volume":"12","author":"M Olbei","year":"2021","unstructured":"Olbei, M. et al. SARS-CoV-2 causes a different cytokine response compared to other cytokine storm-causing respiratory viruses in severely ill patients. Front. Immunol. 12, 629193. https:\/\/doi.org\/10.3389\/fimmu.2021.629193 (2021).","journal-title":"Front. Immunol."},{"key":"9785_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104799","volume":"153","author":"D Darif","year":"2021","unstructured":"Darif, D. et al. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?. Microb. Pathog. 153, 104799. https:\/\/doi.org\/10.1016\/j.micpath.2021.104799 (2021).","journal-title":"Microb. Pathog."},{"issue":"10","key":"9785_CR5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jiph.2020.06.021","volume":"13","author":"N Ali","year":"2020","unstructured":"Ali, N. Role of vitamin D in preventing of COVID-19 infection, progression and severity. J. Infect. Public Health. 13(10), 1373\u20131380. https:\/\/doi.org\/10.1016\/j.jiph.2020.06.021 (2020).","journal-title":"J. Infect. Public Health."},{"key":"9785_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.590459","volume":"11","author":"F Ahmed","year":"2020","unstructured":"Ahmed, F. A network-based analysis reveals the mechanism underlying vitamin D in suppressing cytokine storm and virus in SARS-CoV-2 infection. Front. Immunol. 11, 590459. https:\/\/doi.org\/10.3389\/fimmu.2020.590459 (2020).","journal-title":"Front. Immunol."},{"key":"9785_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/13813455.2020.1792505","author":"M Honardoost","year":"2020","unstructured":"Honardoost, M., Ghavideldarestani, M. & Khamseh, M. E. Role of Vitamin D in pathogenesis and severity of COVID-19 infection. Arch. Physiol. Biochem. https:\/\/doi.org\/10.1080\/13813455.2020.1792505 (2020).","journal-title":"Arch. Physiol. Biochem."},{"issue":"7","key":"9785_CR8","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s40520-020-01570-8","volume":"32","author":"PC Ilie","year":"2020","unstructured":"Ilie, P. C., Stefanescu, S. & Smith, L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin. Exp. Res. 32(7), 1195\u20131198. https:\/\/doi.org\/10.1007\/s40520-020-01570-8 (2020).","journal-title":"Aging Clin. Exp. Res."},{"issue":"4","key":"9785_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/JLB.4COVR1020-698R","volume":"110","author":"V Kalia","year":"2021","unstructured":"Kalia, V., Studzinski, G. P. & Sarkar, S. Role of Vitamin D in regulating COVID-19 severity\u2014An immunological perspective. J. Leukoc. Biol. 110(4), 809\u2013819. https:\/\/doi.org\/10.1002\/JLB.4COVR1020-698R (2021).","journal-title":"J. Leukoc. Biol."},{"key":"9785_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/RMHP.S291584","volume":"14","author":"H Yisak","year":"2021","unstructured":"Yisak, H. et al. Effects of Vitamin D on COVID-19 infection and prognosis: A systematic review. Risk Manag. Healthc. Policy. 14, 31\u201338. https:\/\/doi.org\/10.2147\/RMHP.S291584 (2021).","journal-title":"Risk Manag. Healthc. Policy."},{"issue":"7","key":"9785_CR11","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.3390\/nu12072097","volume":"12","author":"N Charoenngam","year":"2020","unstructured":"Charoenngam, N. & Holick, M. F. Immunologic effects of vitamin D on human health and disease. Nutrients 12(7), 2097. https:\/\/doi.org\/10.3390\/nu12072097 (2020).","journal-title":"Nutrients"},{"issue":"11","key":"9785_CR12","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.3390\/nu10111656","volume":"10","author":"F Sassi","year":"2018","unstructured":"Sassi, F., Tamone, C. & D\u2019Amelio, P. Vitamin D: nutrient, hormone, and immunomodulator. Nutrients 10(11), 1656. https:\/\/doi.org\/10.3390\/nu10111656 (2018).","journal-title":"Nutrients"},{"issue":"4","key":"9785_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/pros.21250","volume":"71","author":"MK Chadha","year":"2011","unstructured":"Chadha, M. K. et al. Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate 71(4), 368\u2013372. https:\/\/doi.org\/10.1002\/pros.21250 (2011).","journal-title":"Prostate"},{"issue":"10","key":"9785_CR14","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s40520-020-01677-y","volume":"32","author":"A Daneshkhah","year":"2020","unstructured":"Daneshkhah, A. et al. Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients. Aging Clin. Exp. Res. 32(10), 2141\u20132158. https:\/\/doi.org\/10.1007\/s40520-020-01677-y (2020).","journal-title":"Aging Clin. Exp. Res."},{"issue":"6","key":"9785_CR15","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s41430-020-0661-0","volume":"74","author":"M Ebadi","year":"2020","unstructured":"Ebadi, M. & Montano-Loza, A. J. Perspective: Improving vitamin D status in the management of COVID-19. Eur. J. Clin. Nutr. 74(6), 856\u2013859. https:\/\/doi.org\/10.1038\/s41430-020-0661-0 (2020).","journal-title":"Eur. J. Clin. Nutr."},{"issue":"7","key":"9785_CR16","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/ajh.25829","volume":"95","author":"E Terpos","year":"2020","unstructured":"Terpos, E. et al. Hematological findings and complications of COVID-19. Am. J. Hematol. 95(7), 834\u2013847. https:\/\/doi.org\/10.1002\/ajh.25829 (2020).","journal-title":"Am. J. Hematol."},{"issue":"10","key":"9785_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239802","volume":"15","author":"J Moutchia","year":"2020","unstructured":"Moutchia, J. et al. Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. PLoS\u00a0One 15(10), e0239802. https:\/\/doi.org\/10.1371\/journal.pone.0239802 (2020).","journal-title":"PLoS\u00a0One"},{"key":"9785_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104611","volume":"131","author":"R Gozalbo-Rovira","year":"2020","unstructured":"Gozalbo-Rovira, R. et al. SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients. J. Clin. Virol. 131, 104611. https:\/\/doi.org\/10.1016\/j.jcv.2020.104611 (2020).","journal-title":"J. Clin. Virol."},{"key":"9785_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.18.210161","author":"R McGregor","year":"2020","unstructured":"McGregor, R. et al. An autocrine vitamin D-driven Th1 shutdown program can be exploited for COVID-19. Preprint. bioRxiv https:\/\/doi.org\/10.1101\/2020.07.18.210161 (2020).","journal-title":"bioRxiv"},{"issue":"8","key":"9785_CR20","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.metabol.2014.05.002","volume":"63","author":"L Mellenthin","year":"2014","unstructured":"Mellenthin, L. et al. Association between serum vitamin D concentrations and inflammatory markers in the general adult population. Metabolism 63(8), 1056\u20131062. https:\/\/doi.org\/10.1016\/j.metabol.2014.05.002 (2014).","journal-title":"Metabolism"},{"issue":"5","key":"9785_CR21","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/ajcn\/nqaa056","volume":"111","author":"S Palaniswamy","year":"2020","unstructured":"Palaniswamy, S. et al. Could vitamin D reduce obesity-associated inflammation? Observational and Mendelian randomization study. Am. J. Clin. Nutr. 111(5), 1036\u20131047. https:\/\/doi.org\/10.1093\/ajcn\/nqaa056 (2020).","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"9785_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11739-011-0559-x","volume":"8","author":"A Bellia","year":"2013","unstructured":"Bellia, A. et al. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern. Emerg. Med. 8(1), 33\u201340. https:\/\/doi.org\/10.1007\/s11739-011-0559-x (2013).","journal-title":"Intern. Emerg. Med."},{"issue":"3","key":"9785_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092614","volume":"9","author":"RA Ghashut","year":"2014","unstructured":"Ghashut, R. A., Talwar, D., Kinsella, J., Duncan, A. & McMillan, D. C. The effect of the systemic inflammatory response on plasma vitamin 25 (OH) D concentrations adjusted for albumin. PLoS\u00a0One 9(3), e92614. https:\/\/doi.org\/10.1371\/journal.pone.0092614 (2014).","journal-title":"PLoS\u00a0One"},{"issue":"4","key":"9785_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.coviro.2011.07.002","volume":"1","author":"T Aoshi","year":"2011","unstructured":"Aoshi, T., Koyama, S., Kobiyama, K., Akira, S. & Ishii, K. J. Innate and adaptive immune responses to viral infection and vaccination. Curr. Opin. Virol. 1(4), 226\u2013232. https:\/\/doi.org\/10.1016\/j.coviro.2011.07.002 (2011).","journal-title":"Curr. Opin. Virol."},{"issue":"7821","key":"9785_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","volume":"584","author":"N Le Bert","year":"2020","unstructured":"Le Bert, N. et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 584(7821), 457\u2013462. https:\/\/doi.org\/10.1038\/s41586-020-2550-z (2020).","journal-title":"Nature"},{"issue":"6","key":"9785_CR26","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.immuni.2020.04.023","volume":"52","author":"L Ni","year":"2020","unstructured":"Ni, L. et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity 52(6), 971-977.e3. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.023 (2020).","journal-title":"Immunity"},{"issue":"16","key":"9785_CR27","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/cid\/ciaa344","volume":"71","author":"J Zhao","year":"2020","unstructured":"Zhao, J. et al. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin. Infect. Dis. 71(16), 2027\u20132034. https:\/\/doi.org\/10.1093\/cid\/ciaa344 (2020).","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"9785_CR28","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","volume":"26","author":"QX Long","year":"2020","unstructured":"Long, Q. X. et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 26(8), 1200\u20131204. https:\/\/doi.org\/10.1038\/s41591-020-0965-6 (2020).","journal-title":"Nat. Med."},{"issue":"2","key":"9785_CR29","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.jinf.2020.04.019","volume":"81","author":"YL Lee","year":"2020","unstructured":"Lee, Y. L. et al. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients. J. Infect. 81(2), e55\u2013e58. https:\/\/doi.org\/10.1016\/j.jinf.2020.04.019 (2020).","journal-title":"J. Infect."},{"issue":"11","key":"9785_CR30","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJMc2025179","volume":"383","author":"FJ Ibarrondo","year":"2020","unstructured":"Ibarrondo, F. J. et al. Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild covid-19. N. Engl. J. Med. 383(11), 1085\u20131087. https:\/\/doi.org\/10.1056\/NEJMc2025179 (2020).","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"9785_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s1074-7613(03)00208-5","volume":"19","author":"G Jego","year":"2003","unstructured":"Jego, G. et al. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19(2), 225\u2013234. https:\/\/doi.org\/10.1016\/s1074-7613(03)00208-5 (2003).","journal-title":"Immunity"},{"issue":"6","key":"9785_CR32","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jiac.2021.01.006","volume":"27","author":"S Kutsuna","year":"2021","unstructured":"Kutsuna, S. et al. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. J. Infect. Chemother. 27(6), 808\u2013813. https:\/\/doi.org\/10.1016\/j.jiac.2021.01.006 (2021).","journal-title":"J. Infect. Chemother."},{"key":"9785_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","volume":"34","author":"CG Vinuesa","year":"2016","unstructured":"Vinuesa, C. G., Linterman, M. A., Yu, D. & MacLennan, I. C. Follicular helper T cells. Annu. Rev. Immunol. 34, 335\u2013368. https:\/\/doi.org\/10.1146\/annurev-immunol-041015-055605 (2016).","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"9785_CR34","doi-asserted-by":"publisher","first-page":"2004234","DOI":"10.1183\/13993003.04234-2020","volume":"57","author":"AA Faniyi","year":"2021","unstructured":"Faniyi, A. A. et al. Vitamin D status and seroconversion for COVID-19 in UK healthcare workers. Eur. Respir. J. 57(4), 2004234. https:\/\/doi.org\/10.1183\/13993003.04234-2020 (2021).","journal-title":"Eur. Respir. J."},{"issue":"9","key":"9785_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239252","volume":"15","author":"HW Kaufman","year":"2020","unstructured":"Kaufman, H. W., Niles, J. K., Kroll, M. H., Bi, C. & Holick, M. F. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS\u00a0One 15(9), e0239252. https:\/\/doi.org\/10.1371\/journal.pone.0239252 (2020).","journal-title":"PLoS\u00a0One"},{"issue":"5","key":"9785_CR36","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1002\/jmv.26832","volume":"93","author":"M Demir","year":"2021","unstructured":"Demir, M., Demir, F. & Aygun, H. Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease. J. Med. Virol. 93(5), 2992\u20132999. https:\/\/doi.org\/10.1002\/jmv.26832 (2021).","journal-title":"J. Med. Virol."},{"issue":"1","key":"9785_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00404-013-2735-x","volume":"288","author":"AG Kebapcilar","year":"2013","unstructured":"Kebapcilar, A. G. et al. Relationship between mean platelet volume and low-grade systemic coagulation with vitamin D deficiency in primary ovarian insufficiency. Arch. Gynecol. Obstet. 288(1), 207\u2013212. https:\/\/doi.org\/10.1007\/s00404-013-2735-x (2013).","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5","key":"9785_CR38","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.11634","volume":"4","author":"Y Li","year":"2021","unstructured":"Li, Y., Tong, C. H., Bare, L. A. & Devlin, J. J. Assessment of the association of vitamin D level with SARS-CoV-2 seropositivity among working-age adults. JAMA Netw. Open. 4(5), e2111634. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.11634 (2021).","journal-title":"JAMA Netw. Open."},{"issue":"11","key":"9785_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14675","volume":"75","author":"R Ghasemian","year":"2021","unstructured":"Ghasemian, R. et al. The role of vitamin D in the age of COVID-19: A systematic review and meta-analysis. Int. J. Clin. Pract. 75(11), e14675. https:\/\/doi.org\/10.1111\/ijcp.14675 (2021).","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"9785_CR40","doi-asserted-by":"publisher","first-page":"20191","DOI":"10.1038\/s41598-020-77093-z","volume":"10","author":"A Jain","year":"2020","unstructured":"Jain, A. et al. Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci. Rep. 10(1), 20191. https:\/\/doi.org\/10.1038\/s41598-020-77093-z (2020).","journal-title":"Sci. Rep."},{"issue":"3","key":"9785_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.5578\/tt.70027","volume":"68","author":"B Kerget","year":"2020","unstructured":"Kerget, B. et al. Evaluation of the relationship of serum vitamin D levels in COVID-19 patients with clinical course and prognosis. COVID-19 hastalar\u0131nda serum vitamin D d\u00fczeyinin klinik seyir ve prognozla ili\u015fkisinin de\u011ferlendirilmesi. Tuberk Toraks. 68(3), 227\u2013235. https:\/\/doi.org\/10.5578\/tt.70027 (2020).","journal-title":"Tuberk Toraks."},{"issue":"2","key":"9785_CR42","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/jmv.26360","volume":"93","author":"R Munshi","year":"2021","unstructured":"Munshi, R. et al. Vitamin D insufficiency as a potential culprit in critical COVID-19 patients. J. Med. Virol. 93(2), 733\u2013740. https:\/\/doi.org\/10.1002\/jmv.26360 (2021).","journal-title":"J. Med. Virol."},{"issue":"1","key":"9785_CR43","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00394-020-02372-4","volume":"60","author":"CE Hastie","year":"2021","unstructured":"Hastie, C. E., Pell, J. P. & Sattar, N. Vitamin D and COVID-19 infection and mortality in UK Biobank. Eur. J. Nutr. 60(1), 545\u2013548. https:\/\/doi.org\/10.1007\/s00394-020-02372-4 (2021).","journal-title":"Eur. J. Nutr."},{"issue":"1149","key":"9785_CR44","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1136\/postgradmedj-2020-138712","volume":"97","author":"V Baktash","year":"2021","unstructured":"Baktash, V. et al. Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad. Med. J. 97(1149), 442\u2013447. https:\/\/doi.org\/10.1136\/postgradmedj-2020-138712 (2021).","journal-title":"Postgrad. Med. J."},{"issue":"4","key":"9785_CR45","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s40618-020-01370-x","volume":"44","author":"GE Carpagnano","year":"2021","unstructured":"Carpagnano, G. E. et al. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J. Endocrinol. Investig. 44(4), 765\u2013771. https:\/\/doi.org\/10.1007\/s40618-020-01370-x (2021).","journal-title":"J. Endocrinol. Investig."},{"issue":"3","key":"9785_CR46","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.cyto.2008.12.009","volume":"45","author":"C Almerighi","year":"2009","unstructured":"Almerighi, C. et al. 1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 45(3), 190\u2013197. https:\/\/doi.org\/10.1016\/j.cyto.2008.12.009 (2009).","journal-title":"Cytokine"},{"issue":"11","key":"9785_CR47","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/jmv.26097","volume":"92","author":"N Ali","year":"2020","unstructured":"Ali, N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J. Med. Virol. 92(11), 2409\u20132411. https:\/\/doi.org\/10.1002\/jmv.26097 (2020).","journal-title":"J. Med. Virol."},{"issue":"12","key":"9785_CR48","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.5858\/arpa.2020-0471-SA","volume":"144","author":"Y Tjendra","year":"2020","unstructured":"Tjendra, Y. et al. Predicting disease severity and outcome in COVID-19 patients: A review of multiple biomarkers. Arch. Pathol. Lab. Med. 144(12), 1465\u20131474. https:\/\/doi.org\/10.5858\/arpa.2020-0471-SA (2020).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"7821","key":"9785_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","volume":"584","author":"DF Robbiani","year":"2020","unstructured":"Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 584(7821), 437\u2013442. https:\/\/doi.org\/10.1038\/s41586-020-2456-9 (2020).","journal-title":"Nature"},{"key":"9785_CR50","doi-asserted-by":"publisher","DOI":"10.1101\/2020.12.07.20245431","author":"AM Sholukh","year":"2020","unstructured":"Sholukh, A. M. et al. Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials. Preprint. medRxiv. https:\/\/doi.org\/10.1101\/2020.12.07.20245431 (2020).","journal-title":"medRxiv."},{"issue":"1","key":"9785_CR51","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1038\/s41467-020-19943-y","volume":"11","author":"K Li","year":"2020","unstructured":"Li, K. et al. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Nat. Commun. 11(1), 6044. https:\/\/doi.org\/10.1038\/s41467-020-19943-y (2020).","journal-title":"Nat. Commun."},{"issue":"5","key":"9785_CR52","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","volume":"20","author":"KK To","year":"2020","unstructured":"To, K. K. et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study. Lancet Infect. Dis. 20(5), 565\u2013574. https:\/\/doi.org\/10.1016\/S1473-3099(20)30196-1 (2020).","journal-title":"Lancet Infect. Dis."},{"issue":"596","key":"9785_CR53","doi-asserted-by":"publisher","first-page":"eabf8654","DOI":"10.1126\/scitranslmed.abf8654","volume":"13","author":"W Hoepel","year":"2021","unstructured":"Hoepel, W. et al. High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages. Sci. Transl. Med. 13(596), eabf8654. https:\/\/doi.org\/10.1126\/scitranslmed.abf8654 (2021).","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"9785_CR54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-021-00525-3","volume":"6","author":"L Gao","year":"2021","unstructured":"Gao, L. et al. The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity. Signal Transduct. Target Ther. 6(1), 113. https:\/\/doi.org\/10.1038\/s41392-021-00525-3 (2021).","journal-title":"Signal Transduct. Target Ther."},{"issue":"9","key":"9785_CR55","doi-asserted-by":"publisher","first-page":"e1619","DOI":"10.1002\/onco.13828","volume":"26","author":"M Esperan\u00e7a-Martins","year":"2021","unstructured":"Esperan\u00e7a-Martins, M. et al. Humoral immune response of SARS-CoV-2-infected patients with cancer: Influencing factors and mechanisms. Oncologist. 26(9), e1619\u2013e1632. https:\/\/doi.org\/10.1002\/onco.13828 (2021).","journal-title":"Oncologist."},{"issue":"1","key":"9785_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010102","volume":"16","author":"A Akter","year":"2022","unstructured":"Akter, A. et al. Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh. PLoS Negl. Trop. Dis. 16(1), e0010102. https:\/\/doi.org\/10.1371\/journal.pntd.0010102 (2022).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"9785_CR57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/v14010080","volume":"14","author":"X Li","year":"2022","unstructured":"Li, X. et al. Patient and clinical factors at admission affect the levels of neutralizing antibodies six months after recovering from COVID-19. Viruses 14(1), 80. https:\/\/doi.org\/10.3390\/v14010080 (2022).","journal-title":"Viruses"},{"issue":"4","key":"9785_CR58","doi-asserted-by":"publisher","first-page":"e00362","DOI":"10.1128\/mSphere.00362-20","volume":"5","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. Clinical characteristics and immune injury mechanisms in 71 patients with COVID-19. mSphere. 5(4), e00362-e420. https:\/\/doi.org\/10.1128\/mSphere.00362-20 (2020).","journal-title":"mSphere."},{"issue":"10","key":"9785_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23483","volume":"34","author":"G Zhao","year":"2020","unstructured":"Zhao, G. et al. A comparative study of the laboratory features of COVID-19 and other viral pneumonias in the recovery stage. J. Clin. Lab. Anal. 34(10), e23483. https:\/\/doi.org\/10.1002\/jcla.23483 (2020).","journal-title":"J. Clin. Lab. Anal."},{"key":"9785_CR60","doi-asserted-by":"publisher","DOI":"10.23736\/S0031-0808.21.04277-4","author":"A Barassi","year":"2021","unstructured":"Barassi, A. et al. Vitamin D in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with non-invasive ventilation support. Panminerva Med. https:\/\/doi.org\/10.23736\/S0031-0808.21.04277-4 (2021).","journal-title":"Panminerva Med."},{"issue":"12","key":"9785_CR61","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/eji.202048970","volume":"50","author":"P Figueiredo-Campos","year":"2020","unstructured":"Figueiredo-Campos, P. et al. Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset. Eur. J. Immunol. 50(12), 2025\u20132040. https:\/\/doi.org\/10.1002\/eji.202048970 (2020).","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"9785_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241104","volume":"15","author":"E Marklund","year":"2020","unstructured":"Marklund, E. et al. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders. PLoS ONE 15(10), e0241104. https:\/\/doi.org\/10.1371\/journal.pone.0241104 (2020).","journal-title":"PLoS ONE"},{"issue":"3","key":"9785_CR63","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s11427-020-1805-0","volume":"64","author":"H Ma","year":"2021","unstructured":"Ma, H. et al. Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge. Sci. China Life Sci. 64(3), 482\u2013485. https:\/\/doi.org\/10.1007\/s11427-020-1805-0 (2021).","journal-title":"Sci. China Life Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09785-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09785-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09785-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:53:55Z","timestamp":1669341235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09785-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9785"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09785-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"29 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5699"}}